Q1 Earnings Decline 20% Amidst Core Customer Losses, Despite Growth in New Segments

summarizeSummary

USANA Health Sciences reported a 20.1% drop in Q1 net earnings and declining customer numbers in its core business, despite flat overall sales driven by growth in its newer Rise segment.

check_boxKey Events

• Net Earnings Decline

  Net earnings attributable to USANA decreased by 20.1% to $7.5 million for Q1 2026, down from $9.4 million in Q1 2025. Diluted EPS also fell to $0.41 from $0.49.

• Core Business Customer Loss

  The Core Nutritional segment experienced a 12.0% decrease in active customers year-over-year, with declines across Asia Pacific and Americas/Europe regions.

• Flat Overall Net Sales

  Consolidated net sales remained largely flat, increasing only 0.3% to $250.2 million, primarily due to significant growth in the newer Rise segment offsetting declines in Core Nutritional and Hiya segments.

• Gross Profit Margin Contraction

  Consolidated gross profit decreased by 280 basis points to 76.2% of net sales, largely due to the incremental sales from the lower-margin Rise segment and production inefficiencies in Core Nutritional.

auto_awesomeAnalysis

This quarterly report details a 20.1% year-over-year decline in net earnings and a decrease in diluted EPS, confirming the preliminary results from the 8-K filed on May 5, 2026. The core nutritional business continues to struggle with a 12% drop in active customers, and the Hiya segment also saw a customer base reduction. While the Rise segment experienced significant sales growth, its lower margins and smaller scale were not enough to offset the declines in the primary business. The company is trading near its 52-week low, making these negative trends particularly concerning for investor sentiment.